Root Cause Analysis: A Key Element Of FDA’s ‘Case For Quality’

CDRH is highlighting poor root cause analysis as part of its “Case for Quality,” an initiative to encourage companies to make quality assurance an organization-wide concern.

More from Archive

More from Medtech Insight